NT5C1A and inclusion body myositis: There was no significant difference between the anti‐NT5C1A antibody‐positive and anti‐NT5C1A antibody‐negative patients’ Kaplan–Meier curves (Fig. 1; log‐rank P = 0.98 in patients with IBM and log‐rank P = 0.19 in patients with IIMs).